Steris rises after second-quarter results beat

By Reuters News

** Shares of Steris PLC STE.N rise 6.5% to $264 in extended trading

** Co posts Q2 fiscal 2027 adjusted profit of $2.94 per share compared with analysts' average estimate of $2.50, according to data compiled by LSEG

** Medical device maker reports quarterly revenue of $1.59 billion versus average estimate of $1.56 billion

** Expects 2027 revenue growth of life sciences segment to be between 9% and 10% compared to its prior outlook in the range of 6% and 7%

** As of last close, stock down 2.1% YTD

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.